Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy, Sven de Mey, Wout de Mey, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 213

Showing 1-25 of 213 citing articles:

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
Magdalena Jarosz‐Biej, Ryszard Smolarczyk, Tomasz Cichoń, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3212-3212
Open Access | Times Cited: 417
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
Wenting Zhang, Qinghua Huang, Weiwei Xiao, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 293
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 253
Endothelial Cells in the Tumor Microenvironment
Katarzyna Sobierajska, Wojciech M. Ciszewski, Izabela Sacewicz‐Hofman, et al.
Advances in experimental medicine and biology (2020), pp. 71-86
Closed Access | Times Cited: 138
Organelle-level precision with next-generation targeting technologies
Anand Saminathan, Matthew Zajac, Palapuravan Anees, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 5, pp. 355-371
Closed Access | Times Cited: 118
Cancer‐associated fibroblast‐derived exosomal microRNA‐20a suppresses the PTEN/PI3K‐AKT pathway to promote the progression and chemoresistance of non‐small cell lung cancer
Lin Shi, Weiliang Zhu, Yuanyuan Huang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 102
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 95
Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma
Jingjia Chang, Hao Wu, Jin Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 45
3D Tumor Models and Their Use for the Testing of Immunotherapies
Nicolas Boucherit, Laurent Gorvel, Daniel Olive
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 136
pH-Sensitive nanogels for drug delivery in cancer therapy
Zhen Li, Jun Huang, Jun Wu
Biomaterials Science (2020) Vol. 9, Iss. 3, pp. 574-589
Closed Access | Times Cited: 134
Delivery of cancer therapies by synthetic and bio-inspired nanovectors
Tina Briolay, Tacien Petithomme, Morgane Fouet, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 88
Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
Marcel Alexander Heinrich, Ahmed M. R. H. Mostafa, Jennifer P. Morton, et al.
Advanced Drug Delivery Reviews (2021) Vol. 174, pp. 265-293
Open Access | Times Cited: 84
An M0 macrophage-related prognostic model for hepatocellular carcinoma
Yiya Zhang, Ju Zou, Ruochan Chen
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 55
Rational Nanomedicine Design Enhances Clinically Physical Treatment‐Inspired or Combined Immunotherapy
Qiaoqiao Liu, Wei Zhang, Rong Jiao, et al.
Advanced Science (2022) Vol. 9, Iss. 29
Open Access | Times Cited: 40
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities
Claire Beckers, Martin Pruschy, Irene Vetrugno
Seminars in Cancer Biology (2023) Vol. 98, pp. 19-30
Open Access | Times Cited: 35
Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives
Hamid Aria, Marzieh Rezaei
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114503-114503
Open Access | Times Cited: 25
Theranostic signature of tumor-derived exosomes in cancer
Samruti Kumar, Rajib Dhar, Lokesh Kumar, et al.
Medical Oncology (2023) Vol. 40, Iss. 11
Closed Access | Times Cited: 23
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses
Weizhou Wang, Junying Fan, Chi Zhang, et al.
Microbiological Research (2024) Vol. 282, pp. 127668-127668
Closed Access | Times Cited: 8
An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
Wen Jiang, Dandan Zhu, Chenghe Wang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 8, pp. 2774-2790
Open Access | Times Cited: 69
Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems
Hui Wang, Heng Jiang, Cyril Corbet, et al.
Cancer Letters (2019) Vol. 450, pp. 42-52
Closed Access | Times Cited: 67
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
Bo Sun, Hyesun Hyun, Liantao Li, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 7, pp. 970-985
Open Access | Times Cited: 64
Targeting Tumor-Associated Macrophages in Anti-Cancer Therapies: Convincing the Traitors to Do the Right Thing
Cristina Belgiovine, Elisabeth Digifico, Clément Anfray, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3226-3226
Open Access | Times Cited: 61
Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
Mehdi Chaib, Subhash C. Chauhan, Liza Makowski
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top